Indefinite Delivery Contract HHSD200200824959I
Award Date 4/1/08
Last Date to Order 4/28/21
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The federal contract IDV award W911QY09D0021 was issued by the Defense agency Bureau of Medicine and Surgery to the prime contractor Camris International, LLC, a for-profit organization that provides professional, scientific, and technical support services to federal agencies. This multiple-award Indefinite Delivery Contract, with a $10,000,000.00 ceiling, supports research and development efforts related to infectious diseases, vaccine development, clinical trials, and emerging public health...
- This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $640,309,577 multiple-award contract, identified as VFA 2009, has an ultimate completion date of June 30, 2010. Under this IDC, Sanofi Pasteur Inc. is the prime contractor responsible for providing a range of vaccine products and services to support various federal...
- This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Adaptimmune LLC, a foreign-owned for-profit manufacturer. The BPA has a ceiling value of $5,525,200.00 and a period of performance ending on June 10, 2026. The BPA is for the procurement of TECELRA products and services. While the specific details of the contracted items are not provided, BPAs are typically used to establish a simplified method of filling anticipated repetitive...
- This Blanket Purchase Agreement was awarded on February 17, 2023, by the U.S. Embassy in San Salvador to Miscellaneous Foreign Awardees, a for-profit subsidiary of Engie Services Zuid B.V., under UEI LN9PU5M2YZN5. The contract carries a ceiling value of $250,000 and operates under a multiple award structure with no set-aside restrictions, indicating open competition procurement methodology. The contract was established to support polymerase chain reaction reverse transcription testing...
- This Blanket Purchase Agreement was awarded as a multiple-award contract by the Department of State US Embassy in Yaounde, Cameroon on November 30, 2020. The agreement enables the Embassy to procure laboratory testing services and supplies from Esri Panama SA doing business as Esri Panama. The potential value of the agreement is $0.00 and it allows ordering through November 29, 2021. Under this agreement, Esri Panama will provide laboratory testing and supply procurement support to the...
- The federal contract IDV award was issued by a U.S. federal government agency to Novartis Vaccines And Diagnostics, Inc., a foreign-owned, for-profit organization. The contract type is an Indefinite Delivery Contract with a potential value of $3,378,319.52. The contract's description is "BIOMEDICAL (BASIC)," indicating it is for basic biomedical products and services. Under this IDV, a single task order was issued with a potential value of $76,625,000.00. This task order, also for...
- The Blanket Purchase Agreement was awarded by the Department of State US Embassy in Yaounde, Cameroon to provide emergency medications and medical supplies as needed. The multiple award IDV has a potential value of $8,627 and a period of performance through December 19, 2023. The prime contractor is a miscellaneous foreign awardee doing business as the Federal Egov IAE Initiative - Generic Entity Identifier. No set-aside provisions were applied to the award. The agreement establishes an...
- This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization. The $80 million IDC is for manufacturing and characterization services for vaccines and other biologics targeting infectious diseases. Under this IDC, ABL has been issued multiple task orders for a range of...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at a ceiling of $669,123,533.05, is for the provision of various vaccine products and related services to support public health missions across multiple federal agencies. The scope of the IDC includes seasonal and pre-pandemic influenza vaccines,...
- HHSD200200824959IIndefinite Delivery Contract
- 11Federal Contract Awards
ACAMBIS, 200-2008-24959
Posted 5/6/08
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00023 | Funding Only Action | $2.8m | 4/28/21 | |
| 23 | Transfer Action | $0 | 10/1/18 | |
| 22 | Funding Only Action | ($29m) | 9/28/18 | |
| 21 | Funding Only Action | ($6m) | 9/6/18 | |
| 20 | Other Administrative Action | $0 | 3/23/18 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HHSD200200824959I-HHSD2002008249590010 | Sanofi Pasteur Biologics, LLC | $2.4m | 7/11/17 | 3/31/18 | 7/11/17 | |
Delivery Order HHSD200200824959I-HHSD2002008249590007 | Emergent Biodefense Operations Lansing LLC | $37.9m | 9/30/15 | 3/31/19 | 10/1/18 | |
Delivery Order HHSD200200824959I-HHSD2002008249590006 | Sanofi Pasteur Biologics, LLC | $1.6m | 7/10/15 | 6/23/16 | 8/11/15 | |
Delivery Order HHSD200200824959I-HHSD2002008249590011 | Emergent Biodefense Operations Lansing LLC | $38.4m | 9/21/17 | 1/31/19 | 8/3/18 | |
Delivery Order HHSD200200824959I-HHSD2002008249590009 | Emergent Biodefense Operations Lansing LLC | $38.3m | 9/30/16 | 8/31/18 | 4/9/18 |